e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Clinical aspects of diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cryptogenic organising pneumonia – just a manifestation of community acquired pneumonia? A retrospective analysis from 1995 to 2004
A. Dittrich, W. R. Guschall, G. Liebetrau (Lostau, Neuruppin, Germany)
Source:
Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Session:
Clinical aspects of diffuse parenchymal lung disease
Session type:
Thematic Poster Session
Number:
731
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Dittrich, W. R. Guschall, G. Liebetrau (Lostau, Neuruppin, Germany). Cryptogenic organising pneumonia – just a manifestation of community acquired pneumonia? A retrospective analysis from 1995 to 2004. Eur Respir J 2009; 34: Suppl. 53, 731
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Imaging of complicated pneumonia: what is new?
Related content which might interest you:
Cryptogenic organizing pneumonia in Spain. Study of 309 patients (1985-2002)
Source: Eur Respir J 2004; 24: Suppl. 48, 535s
Year: 2004
Incidence, aetiology and long-term evaluation of parapneumonic effusions complicated community acquired pneumonia during the period 1994-2008 in northern Greece
Source: Annual Congress 2009 - Bacterial infections of upper and lower respiratory tract in childhood
Year: 2009
Aetiology and outcome of severe community-acquired pneumonia: overview of ICU cases on 1998
Source: Eur Respir J 2001; 18: Suppl. 33, 404s
Year: 2001
"Masks" of severe pneumonia (retrospective analysis of letal severe community-acquired pneumonia (sCAP))
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
Pneumocystis pneumonia in non-HIV patients. A retrospective study (2000-2007)
Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Year: 2008
Cryptogenic organising pneumonia
Source: Eur Respir J 2006; 28: 1291
Year: 2006
Cryptogenic organising pneumonia
Source: Eur Respir J 2006; 28: 422-446
Year: 2006
Etiology of community-acquired pneumonia: an autopsy study
Source: Annual Congress 2006 - Miscellaneous respiratory infections I
Year: 2006
Hospital admissions of adults with community-acquired pneumonia in Portugal between 2000 and 2009
Source: Eur Respir J 2013; 41: 1141-1146
Year: 2013
Health care associated pneumonia (HCAP) and community acquired pneumonia (CAP): Are they different diseases?
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Cryptogenic organizing pneumonia: a relapsing disease
Source: Eur Respir J 2004; 24: Suppl. 48, 507s
Year: 2004
Eosinophilic pneumonia – Our own experience with diagnosis and treatment
Source: Annual Congress 2012 - The good clinical practice: useful case report
Year: 2012
Pro-vasopressin (copeptin) in patients with community-acquired pneumonia – influence of antibiotic pre-treatment; results from the German competence network CAPNETZ
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009
What is pneumonia?
Source: Breathe, 17 (3) 210087; 10.1183/20734735.0087-2021
Year: 2021
Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
Nosocomial pneumonia and non invasive ventilation in a tertiary public hospital – an observational study
Source: Annual Congress 2009 - New trends in noninvasive ventilation for acute respiratory failure
Year: 2009
Risk factors for severe bronchiolitis – A retrospective study
Source: Annual Congress 2012 - Paediatric respiratory epidemiology. Wheeze: where, how and why?
Year: 2012
Community-acquired complicated parapneumonic effusions in adults without associated comorbidity – A study from India
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept